Skip to Main content Skip to Navigation
Journal articles

Evaluation of a new random-access HBV DNA molecular assay: The VERIS HBV assay.

Résumé : Detection and quantification of HBV DNA are essential to diagnose chronic HBV infection, monitor the virological response to treatment and the possible selection of resistant viruses in order to tailor therapy. The VERIS/MDx System HBV Assay is a random-access system that quantifies HBV DNA in clinical samples using unique single sample and reagent access during the workflow process without the need to reload other tests and delivers results within 1.2h following sampling.
Document type :
Journal articles
Complete list of metadatas

https://www.hal.inserm.fr/inserm-01528451
Contributor : Slim Fourati <>
Submitted on : Monday, May 29, 2017 - 10:29:10 AM
Last modification on : Wednesday, August 19, 2020 - 11:17:24 AM

Identifiers

  • HAL Id : inserm-01528451, version 1
  • PUBMED : 28549336

Collections

Citation

Slim Fourati, Dominique Challine, Jean-Dominique Poveda, Syria Laperche, Sandrine Rallier, et al.. Evaluation of a new random-access HBV DNA molecular assay: The VERIS HBV assay.. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2017, 92, pp.69-74. ⟨inserm-01528451⟩

Share

Metrics

Record views

251